Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

GENE
Genetic Technologies Ltd.
stock NASDAQ

Inactive
Oct 16, 2024
0.7650USD-1.923%(-0.0150)22,667
Pre-market
0.00USD0.000%(0.00)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 19, 2022
09:00AM EST  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GENE, geneType), a diversified Genomics and AI driven preventative health business, provides its results for the quarter ended December 31, 2021.   GlobeNewswire Inc
Jan 11, 2022
10:38AM EST  52 Weeks High And Low Article   Benzinga
Dec 21, 2021
08:00AM EST  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE,   GlobeNewswire Inc
Dec 10, 2021
07:39AM EST  Genetic Technologies Highlights Presentation Of 200K-Participant Study At San Antonio Breast Cancer Symposium   Benzinga
07:30AM EST  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GENE), a global leader in genomics-based tests in health, wellness and serious disease confirms that the Companys Director of Clinical Affairs & Medical Education, Erika Spaeth, PhD will be presenting at 2021 San Antonio Breast Cancer Symposium.   GlobeNewswire Inc
Dec 9, 2021
09:46PM EST  Genetic Technologies Announces New Partnership And geneType COVID-19 Risk Test Patent Allowance From The USPTO   Benzinga
Oct 25, 2021
08:30AM EDT  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GTG), a global leader in Genomics based tests in health, wellness and serious disease provides its results for its first quarter of fiscal year 2022, ended September 30, 2021.   GlobeNewswire Inc
05:08AM EDT  Genetic Technologies Reported Q1 FY22 Cash Receipts of A$850,000, a Material Increase vs Prior Quarter   Benzinga
Oct 4, 2021
08:00AM EDT  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GENE), a global leader in genomics-based tests in health, wellness and serious disease, announces a 12-fold increase in revenue generated during the September 2021 quarter to A$850k1.   GlobeNewswire Inc
05:07AM EDT  Genetic Technologies Announced Material Increase in Cash Receipts; Co Reported Preliminary Cash Receipts of A$850k for September 2021 Quarter vs A$68k in June 2021 Quarter   Benzinga
Sep 30, 2021
09:00AM EDT  Genetic Technologies Limited Interview to Air on Bloomberg TV (U.S   GlobeNewswire Inc
Sep 28, 2021
08:08AM EDT  Genetic Technologies Limited Announces Collaboration With Institute of Public Health in St Louis For 'expanding the predictive capabilities of the GeneType for Breast Cancer product to include women of African descent.'   Benzinga
08:04AM EDT  GENE Embarks on Breakthrough African American Collaboration for   GlobeNewswire Inc
Sep 13, 2021
01:40PM EDT  Genetic Technologies Issues Report IN 6-K Filing   Benzinga
Sep 9, 2021
09:02AM EDT  BelHealth Completes Asset Sale of General Genetics Corp.   PR Newswire
Aug 31, 2021
09:06AM EDT  Genetic Technologies FY21 Sales From Customers A$120K   Benzinga
09:00AM EDT  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GTG), a global leader in Genomics based tests in health, wellness and serious disease, is pleased to provide the financial results for the year ended June 30, 2021.   GlobeNewswire Inc
Aug 16, 2021
08:01AM EDT  Genetic Technologies Shares Spike After Co. Announced Completion Of EasyDNA Acquisition   Benzinga
08:00AM EDT  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GENE), a global leader in Genomics based tests in health, wellness and serious disease, is pleased to announce the completion of its acquisition of EasyDNA (the acquisition) for US$4 million in cash and stock on August 13, 2021.   GlobeNewswire Inc
Jul 27, 2021
11:13AM EDT  Genetic Technologies Limited Granted US Patent Titled 'Methods For Breast Cancer Risk Assessment'   Benzinga
Jul 26, 2021
05:15PM EDT  Sundial Growers, MedMen, World Acceptance Among Top Cannabis Stock Movers On July 26, 2021   Benzinga
08:26AM EDT  Genetic Technologies Reports Q3 2021 Revs A$99K   Benzinga
08:25AM EDT  Genetic Technologies Limited (NASDAQ: GENE, Company, GTG), a global leader in Genomics based tests in health, wellness and serious disease, is pleased to provide its Quarterly Business Update to the market.   GlobeNewswire Inc
Jul 19, 2021
09:27AM EDT  Genetic Technologies Acquires EasyDNA To Expand Into Wellness Testing   Benzinga
08:10AM EDT  Genetic Technologies Announces Agreement To Acquire EasyDNA From BelHealth Investment Fund LP As Majority Owner For $4M In Cash And GTG ADRs   Benzinga
08:00AM EDT  Genetic Technologies Strengthens Global Leadership in Genomics   GlobeNewswire Inc
Jul 15, 2021
05:33PM EDT  World Acceptance, Cresco Labs And TerrAscend Among Top Cannabis Stock Movers On July 15, 2021   Benzinga
Jul 9, 2021
08:49AM EDT  UPDATE: Genetic Technologies Says Polygenic Risk Scores For Ovarian, Pancreatic Cancer In Late Stage Development With Product Launch Scheduled For 2021   Benzinga
08:48AM EDT  UPDATE: Genetic Technologies Says Plans To Incorporate New Clinical Risk Models Into The Polygenic Tests Which Are Currently Under Development, Undergoing Validation In Large-Scale Cohort Studies   Benzinga
08:45AM EDT  UPDATE: Genetic Technologies Says Expects To Release Results By End Of 2021 Showing Recent Advancements In Its Tests That Have Helped Identify Informative Polygenic Risk Scores That Could Enhance Predictability   Benzinga
08:39AM EDT  UPDATE: Genetic Technologies Offers 6 Key Highlights Related To Development Of Its Predictive Risk Test for Multiple Cancers, Morbidities   Benzinga
08:22AM EDT  Genetic Technologies Highlights Development Of Its Predictive Risk Test For Multiple Cancers & Morbidities   Benzinga
08:00AM EDT  Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE, "Company", "GTG"), a diversified Genomics and AI driven preventative health business,today announced updates on the development of its Predictive Panel Risk Test designed to cover six different cancers including breast and colorectal cancer, prostate and ovarian cancer, pancreatic cancer and melanoma.   GlobeNewswire Inc
Jul 7, 2021
05:33PM EDT  Sundial Growers, Cresco Labs, RIV Capital Among Top Cannabis Stock Movers On July 7, 2021   Benzinga
Jun 11, 2021
05:13PM EDT  Cannabis Stock Gainers And Losers From June 11, 2021   Benzinga
08:00AM EDT  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GTG), a diversified Genomics and AI driven preventative health business, has been granted US Patent No. 11,031,098 Computer Systems and Methods for Genomic Analysis.   GlobeNewswire Inc
05:20AM EDT  Genetic Technologies Announced US Patent Office Grants Foundational Pharmacogenomic Patent   Benzinga
Jun 9, 2021
11:10AM EDT  Infinity BiologiX, Genetic Technologies And Vault Heath Launch New Test To Assess Severity Of COVID-19 In Individuals   Benzinga
Jun 1, 2021
05:17PM EDT  Cannabis Stock Gainers And Losers From June 1, 2021   Benzinga
08:00AM EDT  Genetic Technologies COVID-19 Risk Test Now   GlobeNewswire Inc
07:06AM EDT  Shares in Genetic Technologies Resume Trading   Benzinga
05:11AM EDT  Genetic Technologies Announced its GTG COVID-19 Risk Test Was Launched in the US   Benzinga
May 28, 2021
06:47AM EDT  Genetic Technologies Shares Halted By Nasdaq With Code News Pending   Benzinga
05:16AM EDT  Genetic Technologies Shares Were Halted on the ASX 'in Anticipation of an Update Regarding the Company's COVID-19 Serious Disease Risk Test'   Benzinga
May 13, 2021
09:01AM EDT  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GTG), a diversified Genomics and AI driven preventative health business, today announced an interview with Simon Morriss, CEO, will air on The RedChip Money Report on the Bloomberg Network in the U.S. on Saturday, May 15th, at 7 p.m. local time in 73M homes across the United States.   GlobeNewswire Inc
May 6, 2021
05:18PM EDT  Cannabis Stock Gainers And Losers From May 6, 2021   Benzinga
Apr 29, 2021
11:45AM EDT  Genetic Technologies Reports Q3 2021 Cash Balance A$22.98M; Reports Net Cash Used For Operations Of A$1.08M   Benzinga
Apr 26, 2021
08:00AM EDT  Genetic Technologies COVID-19 Risk Test Approved   GlobeNewswire Inc
05:28AM EDT  Genetic Technologies Announced its Covid- 19 Risk Test Approved for Commercial Release; Commercial Release Is Expected to Occur No Later Than the End of May   Benzinga
Apr 21, 2021
03:34PM EDT  Cannabis Stock Gainers And Losers From February 23, 2021   Benzinga
Apr 12, 2021
08:15AM EDT  Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company), announces the appointment of Michael Tonroe to the role of Chief Financial Officer, commencing on 28 June 2021.   GlobeNewswire Inc
06:23AM EDT  Genetic Technologies Appoints Michael Tonroe CFO   Benzinga
Apr 9, 2021
11:15AM EDT  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company, GTG), a diversified Genomics and AI driven preventative health business provides an update to the market on the progress of the US commercial availability of the Companys COVID-19 Serious Disease Risk (COVID-19 Risk Test) via US Based Infinity BiologiX LLC (IBX), (ref: ASX Announcement 3 March 2021).   GlobeNewswire Inc
06:13AM EDT  Genetic Technologies Reports Has Completed All Validation For ITs COVID-19 Risk Test; Co. Working With US-Based Distribution Partner To Plan For Commercial Availability Of The Test In The US   Benzinga
Mar 12, 2021
11:06AM EST  Genetic Technologies Shares Halted On Circuit Breaker To Upside, Traders Circulate medRxiv Listing For Co.'s 'Development and validation of a clinical and genetic model for predicting risk of severe COVID-19'   Benzinga
Mar 4, 2021
07:04AM EST  Genetic Technologies Signs Multi-Year US Distribution Agreement With Infinity BiologiX for COVID Risk Test   Benzinga
07:00AM EST  Genetic Technologies Signs Multi-Year US Distribution Agreement   GlobeNewswire Inc
Mar 3, 2021
05:33AM EST  Shares of Genetic Technologies Resumed Trading at 4:10 AM ET After Distribution Agreement Announcement   Benzinga
05:31AM EST  Genetic Technologies Announced a Co-exclusive Production and Distribution Rights and License Agreement with Infinity BiologiX LLC for its COVID-19 Serious Disease Risk Test in the U.S.   Benzinga
Mar 2, 2021
05:38AM EST  Shares of Genetic Technologies Were Halted on Monday Evening: News Pending   Benzinga
Feb 26, 2021
09:29AM EST  Genetic Technologies CMO George Muchnicki To Interview On Bloomberg TV Saturday, Feb. 27 At 3 a.m. EST   Benzinga
09:20AM EST  Genetic Technologies Limited Interview to Air on Bloomberg TV in   GlobeNewswire Inc
05:42AM EST  Genetic Technologies Reported Early-stage Revenue of $16k Associated with Sale of Launched Products for H1 2021; Says has Analysed Data on 6,500+ Infected Patients With Covid-19 PRS Test   Benzinga
Feb 23, 2021
05:44PM EST  Cannabis Stock Gainers And Losers From February 23, 2021   Benzinga
Feb 16, 2021
11:51AM EST  Watching Genetic Technologies Shares Amid US Patent & Trademark Office Abstract For Co.'s 'Method for modifying a treatment regimen of a human female subject'   Benzinga
Jan 28, 2021
05:23AM EST  Genetic Technologies Reported Wednesday a Cash Balance of A$16.43M as of December 31, 2020; Net Cash for Operations of A$1.48M vs Prior Quarter A$1.88M   Benzinga
Jan 25, 2021
04:00PM EST  Genetic Technologies Announces Closing of $6.56 Million Registered   GlobeNewswire Inc
Jan 21, 2021
05:51PM EST  Genetic Technologies Earlier Announced A $6/56M Offering   Benzinga
11:30AM EST  Genetic Technologies Announces $6.56 Million Registered Direct   GlobeNewswire Inc
10:23AM EST  Shares Genetic Technologies Ltd. (GENE) are currently surging over 65% after the molecular diagnostics company provided update on its COVID-19 PRS test.   RTTNews
10:11AM EST  Mid-Morning Market Update: Markets Mixed; Union Pacific Profit Beats Views   Benzinga
07:25AM EST  Genetic Technologies shares are trading higher after the company provided an update on its COVID-19 severity risk test, saying predictive capabilities improved 100% over age and sex alone.   Benzinga
07:02AM EST  Genetic Technologies Also Discusses Expansion Into Germline Testing   Benzinga
07:02AM EST  Genetic Technologies Provides Update On COVID-19 Disease Severity Risk Test; Says 'Predictive capabilities improved 100% over age and sex alone'   Benzinga
07:00AM EST  Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, Company), provides the following update to the market on further development on the COVID-19 serious disease risk Polygenic Risk Score Test (COVID-19 PRS Test) and expansion of the Companys offering to include Germline Testing division.   GlobeNewswire Inc
Jan 4, 2021
05:52AM EST  Genetic Technologies Named Simon Morriss as CEO   Benzinga
Dec 2, 2020
09:00AM EST  Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, the Company), announced today that they have entered into a three-year partnership agreement with mental health company, Taliaz, for the distribution rights of their PREDICTIX products in Australia, New Zealand and the USA (Agreement).   GlobeNewswire Inc
Nov 30, 2020
06:37PM EST  Genetic Technologies Announced Agreement for Distribution Rights of Taliaz's Predictix Products in Australia, New Zealand and US   Benzinga
Nov 23, 2020
04:30PM EST  Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, Company)is pleased to announce an interview with its interim-CEO, Dr. Jerzy Muchnicki aired on The RedChip Money Report television program. The RedChip Money Report airs in 100 million homes on Sundays at 6 p.m. local time in every country in Europe on Bloomberg International.   GlobeNewswire Inc
Nov 17, 2020
08:30AM EST  Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, Company)is pleased to announce its interim-CEO, Dr. Jerzy Muchnicki, will share insight into the companys recent developments during an investor webinar on Thursday, November 19, 2020 at 4:15 p.m. ET. A live Q&A session with Dr. Muchnicki will follow the presentation.   GlobeNewswire Inc
Oct 22, 2020
02:28PM EDT  Genetic Technologies In 20F Filing Says 'In response to the global COVID-19 pandemic, we have completed the development of our COVID-19 risk test'   Benzinga
Oct 1, 2020
11:57AM EDT  Genetic Technologies shares are trading higher after the company announced the publication of findings related to its Covid-19 risk test in the andmedRxiv journal.   Benzinga
08:01AM EDT  Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, Company), provides the following update to the market on the development of the Companys COVID-19 Risk Test.   GlobeNewswire Inc
Sep 15, 2020
08:01AM EDT  Genetic Technologies Provides Update On COVID-19 Disease Severity Test Development   Benzinga
08:00AM EDT  Genetic Technologies Provides Update on COVID-19 Disease Severity   GlobeNewswire Inc
Sep 11, 2020
08:40AM EDT  Genetic Technologies Reports US Sales Have Commenced Via Online Health Platform   Benzinga
08:34AM EDT  Genetic Technologies Announces US Sales Have Commenced via Online   GlobeNewswire Inc
05:37AM EDT  Genetic Technologies Announces Sales of its GeneType for Breast Cancer Risk Assessment Commenced in the U.S. via Online Health Platform   Benzinga
Sep 1, 2020
04:46PM EDT  Genetic Technologies Regains Compliance With Nasdaq Stockholders Equity Requirement   Benzinga
04:45PM EDT  Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the Company), a leader in the development of genetic risk assessment tests, is pleased to announce that it received notification from theListing Qualifications Departmentof theNasdaq Stock Marketindicating that the Company has met the minimum stockholders equity requirement set forth in Listing Rule 5550(b)(1).   GlobeNewswire Inc
Jul 30, 2020
05:44PM EDT  Cannabis Stock Gainers And Losers From July 30, 2020   Benzinga
Jul 29, 2020
07:50AM EDT  Gene Technologies Spikes Higher, Above $5 Level, After Company Reports Quarterly Activities Report   Benzinga
Jul 20, 2020
08:30PM EDT  Genetic Technologies Announces Closing of $5.1 Million Registered   GlobeNewswire Inc
10:12AM EDT  Mid-Morning Market Update: Markets Mixed; Halliburton Profit Beats Views   Benzinga
Jul 16, 2020
08:05AM EDT  Genetic Technologies Announces $5.1M Offering At $5/Share   Benzinga
08:04AM EDT  Genetic Technologies Prices 1.025M ADS Offering At $5/ADS   Benzinga
08:03AM EDT  Genetic Technologies Announces $5.1 Million Registered Direct Offering   GlobeNewswire Inc
05:27AM EDT  Shares of Genetic Technologies Halted on ASX Pending Query into Price Movement   Benzinga
Jul 15, 2020
02:43PM EDT  Mid-Afternoon Market Update: Dow Surges Over 200 Points; Moleculin Biotech Shares Climb   Benzinga
12:12PM EDT  Mid-Day Market Update: Nasdaq Turns Negative; Immutep Shares Spike Higher   Benzinga
10:48AM EDT  Shares of Genetic Technologies Ltd. (GENE) shares surged over 50% on Wednesday morning. The molecular diagnostics company said it has filed a provisional patent for its COVID-19 Severity Risk Test with the Patent Office in Australia.   RTTNews
10:13AM EDT  Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Beats Q2 Expectations   Benzinga
08:00AM EDT  Genetic Technologies Provides Update on COVID-19 Disease Severity Test   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC